Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simafex is a French pharmaceutical company specializing in the chemical synthesis of Active Pharmaceutical Ingredients (APIs), primarily for use in diagnostic imaging. Located in Bagnols-sur-Cèze, the company serves as a strategic manufacturing site for its parent company, Guerbet, focusing on the production of iodine-based contrast agents. Simafex is recognized for its expertise in complex organic chemistry and large-scale industrial production under strict Good Manufacturing Practice (GMP) standards. The facility plays a critical role in the global supply chain for radiology and interventional imaging products, supporting the development of contrast media for X-ray and CT examinations. Its capabilities include the synthesis of specialized molecules such as iobitridol and ioversol.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Simafex.